Dorsey Wright & Associates Novo Nordisk A S Transaction History

Dorsey Wright & Associates

$376 Million
Q2 2024

A detailed history of Dorsey Wright & Associates transactions in Novo Nordisk A S stock. As of the latest transaction made, Dorsey Wright & Associates holds 54,585 shares of NVO stock, worth $7.16 Million. This represents 2.07% of its overall portfolio holdings.

Number of Shares

54,585

Previous 56,435 3.28%

Holding current value

$7.16 Million

Previous $7.25 Million 7.52%

% of portfolio

2.07%

Previous 1.92%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$122.71 - $146.91 $227,013 - $271,783	-1,850 Reduced 3.28%	54,585 $7.79 Million
Q1 2024 May 08, 2024	SELL	$102.11 - $135.92 $340,434 - $453,157	-3,334 Reduced 5.58%	56,435 $7.25 Million
Q4 2023 Feb 13, 2024	SELL	$87.78 - $105.45 $407,650 - $489,709	-4,644 Reduced 7.21%	59,769 $6.18 Million
Q3 2023 Nov 07, 2023	BUY	$90.94 - $199.54 $2.74 Million - $6.01 Million	30,137 Added 87.92%	64,413 $5.86 Million
Q2 2023 Jul 26, 2023	SELL	$155.98 - $172.65 $537,195 - $594,606	-3,444 Reduced 9.13%	34,276 $5.55 Million
Q1 2023 Apr 19, 2023	SELL	$132.34 - $159.14 $332,438 - $399,759	-2,512 Reduced 6.24%	37,720 $6 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $458,808 - $605,466	-4,474 Reduced 10.01%	40,232 $5.44 Million
Q2 2022 Jul 20, 2022	SELL	$103.24 - $121.81 $549,030 - $647,785	-5,318 Reduced 10.63%	44,706 $4.98 Million
Q1 2022 Apr 27, 2022	SELL	$93.1 - $112.54 $139,929 - $169,147	-1,503 Reduced 2.92%	50,024 $5.56 Million
Q4 2021 Jan 27, 2022	BUY	$95.88 - $117.08 $97,126 - $118,602	1,013 Added 2.01%	51,527 $5.77 Million
Q3 2021 Oct 26, 2021	BUY	$84.42 - $106.62 $4.26 Million - $5.39 Million	50,514 New	50,514 $4.85 Million
Q1 2021 Apr 27, 2021	SELL	$67.06 - $75.82 $3.98 Million - $4.5 Million	-59,319 Closed	0 $0
Q4 2020 Jan 28, 2021	SELL	$63.89 - $73.8 $52,453 - $60,589	-821 Reduced 1.37%	59,319 $4.14 Million
Q3 2020 Oct 28, 2020	BUY	$63.69 - $70.22 $55,155 - $60,810	866 Added 1.46%	60,140 $4.18 Million
Q2 2020 Jul 23, 2020	SELL	$58.54 - $67.94 $284,797 - $330,528	-4,865 Reduced 7.59%	59,274 $3.89 Million
Q1 2020 Apr 20, 2020	BUY	$49.46 - $64.78 $887,262 - $1.16 Million	17,939 Added 38.83%	64,139 $3.86 Million
Q4 2019 Jan 31, 2020	BUY	$49.86 - $58.26 $2.3 Million - $2.69 Million	46,200 New	46,200 $2.67 Million

Others Institutions Holding NVO

# of Institutions

1,988

Shares Held

318M

Call Options Held

5.23M

Put Options Held

4.97M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $296B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey Wright & Associates with notifications on news.

Account

Dorsey Wright & Associates Novo Nordisk A S Transaction History